<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862093/" ref="ordinalpos=1051&amp;ncbi_uid=2311562&amp;link_uid=PMC2862093" image-link="/pmc/articles/PMC2862093/figure/F6/" class="imagepopup">Figure 6. Proposed GLP-1R signal transduction scheme.  From: Glucagon-like Peptide-1 Receptor (GLP-1R) is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">In our previous work we demonstrated that GLP-1 or Exendin-4 increased cAMP production. Here we propose that the GLP-1 action shares key downstream components of the insulin signaling pathway, including PKCÎ¶, which has been shown to be a key factor in NAFLD.</div></div>